Evidence map›Paper›PMID 34961497›Full record

ArticleBMC ophthalmology2021

Analysis of a two-year independent screening effort for retinopathy of prematurity in rural Egypt.

Sara Tawfik, Ahmed Mansour, Norhan Lotfy Selim, Ahmed M Habib, Yousef A Fouad, Mohamed A Tawfik, Mariam Al-Feky

Abstract read
In one paragraph

Article in BMC ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sara TawfikAl Ferdaws Eye Hospital, Sharkia, Egypt.
Ahmed MansourAl Mashreq Eye Center, 102 El-Sayed El-Merghany St., Cairo, 11774, Egypt.
Norhan Lotfy SelimAl Ferdaws Eye Hospital, Sharkia, Egypt.
Ahmed M HabibAl Mashreq Eye Center, 102 El-Sayed El-Merghany St., Cairo, 11774, Egypt.
Yousef A FouadAl Mashreq Eye Center, 102 El-Sayed El-Merghany St., Cairo, 11774, Egypt. yousef.a.fouad@gmail.com.
Mohamed A TawfikAl Ferdaws Eye Hospital, Sharkia, Egypt.
Mariam Al-FekyAl Mashreq Eye Center, 102 El-Sayed El-Merghany St., Cairo, 11774, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe third epidemic of retinopathy of prematurity (ROP) has majorly involved middle income countries in which tailored screening and local guidelines require development. The data regarding ROP prevalence and cutoff numbers for screening in Egypt are lacking.

methodsRetrospective analysis of an independent screening effort spanning 2 years (February 2019 to February 2021) and involving 32 neonatal care units within Sharkia governorate, Egypt. Infants of gestational age (GA) ≤ 34 weeks and/or birth weight (BW) ≤ 2000 g were included, as well as those with unstable clinical course. Two eyecare centers located in Sharkia and Cairo governorates served as referral centers for any required interventions.

resultsOf the 276 screened infants, 133 (48.2%) had some form of ROP that was bilateral in 127 (95.5%) of them. Aggressive posterior ROP (AP-ROP) was detected in both eyes of 24 infants (8.7%). The median (IQR) GA of infants with ROP was 32 (30-34) weeks, and the median (IQR) BW was 1600 (1350-2000) g. Sixty-three infants (47.4%) required treatment. Of the total 84 eyes that primarily were treated, 73 (86.9%) received intravitreal ranibizumab, 8 (9.5%) underwent laser ablation therapy, and 3 eyes (3.6%) underwent surgery. Recurrence rate was 16.7% (14 eyes). Final outcome was favorable in 83 eyes (98.8%). Applying the American Academy criteria would have led to the missing of 36.8% of infants with ROP and 28.6% of those requiring treatment in our sample.

conclusionThe incidence of both ROP and AP-ROP in the Egyptian rural setting appears to be in the high end of global reported rates. Prevention measures should urgently be planned and implemented.

Indexed as

Retinopathy of PrematurityEgyptGestational AgeHumansIncidenceInfantInfant, NewbornNeonatal ScreeningRetrospective StudiesRisk FactorsAggressive Posterior Retinopathy of PrematurityRanibizumabRetinopathy of PrematurityROPScreening

Identifiers

PMID34961497
PMCPMC8711162

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.